Photo from the archive of Indira Gandhi International Airport, one of the busiest in the world, in New Delhi, India, November 2, 2016.
Nicolas Economou | NurPhoto | Getty Images
After closing its borders to foreign visitors for 20 months due to the pandemic, India will now allow fully vaccinated foreign travelers from a list of nearly 100 countries to enter without the need for quarantine.
V rules updated last weekIndia advised that travelers arriving from these countries will be allowed to skip a Covid test upon arrival, but will have to monitor their health for the next 14 days.
As of November 13, there were 99 countries on this list including USA, UK, Singapore, Australia, Germany, France and Brazil.
The countries on the list are divided into two categories:
1. Persons who have mutual agreements with the Government of India to recognize each other’s vaccine certificates either for locally approved vaccines or for vaccines recognized by the World Health Organization;
2. and countries that do not have such agreements but allow fully vaccinated Indian citizens to travel.
Visitors from countries not included in the list will be required to take a Covid test upon arrival, then spend 7 days in home quarantine and have another test on day 8, regardless of their vaccination status.
Notable countries missing from this list of 99 countries include China, Japan, South Korea, and Indonesia.
India experienced a devastating second wave, which peaked in early May. This pushed the country’s health care system to the brink as the number of Covid-19 cases skyrocketed and hospital beds and other medical supplies ran out. Since then, the number of cases has decreased and the vaccination rate has increased slightly.
Information compiled by the online publication Our World in Data showed that 7-day rolling average of Covid cases per million people On October 31, it fell below 10 and remained at this level as of November 14. At its peak in May, that number peaked at 280.
However, due to limited testing, the number of confirmed cases remains lower than the actual number of infections.
India reached a notable vaccination milestone last month – it has administered more than 1 billion doses of Covid-19 vaccine since the start of its ambitious vaccination program in January.
Yet, just under 40% of the eligible population was fully vaccinated, below the rate required to meet New Delhi’s requirements. previously announced target vaccination of every adult by the end of the year.
Since the start of the vaccination program, India has approved several vaccines. These include a vaccine developed by AstraZeneca and Oxford University, known as Covishield and manufactured by the Serum Institute, as well as Covaxin Bharat Biotech and Russia’s Sputnik-V.
Both Covishield and Covaxin have been approved for emergency use by the World Health Organization.
India also reportedly approved it is the first vaccine for people under 18 years of age – a three-dose shot made by Indian drug manufacturer Cadila Healthcare.